Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.280
-0.050 (-3.76%)
Sep 11, 2026, 4:08 PM HKT
Viva Biotech Holdings Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,004 | 1,089 | 941.71 | 1,036 | 678.57 | 800.95 |
Short-Term Investments | 20.57 | - | - | - | - | - |
Cash & Short-Term Investments | 1,025 | 1,089 | 941.71 | 1,036 | 678.57 | 800.95 |
Cash Growth | 13.33% | 15.62% | -9.13% | 52.72% | -15.28% | -66.03% |
Accounts Receivable | 250.51 | 386.3 | 420.46 | 407.41 | 445.97 | 429.7 |
Other Receivables | 4.53 | 242.94 | 61.24 | 136.13 | 59.41 | 102.2 |
Receivables | 255.04 | 629.24 | 481.7 | 543.53 | 505.38 | 531.9 |
Inventory | 398.69 | 335.74 | 272.7 | 259.71 | 326.03 | 231.72 |
Prepaid Expenses | - | 9.34 | 8.31 | 5.95 | 7.94 | 7.26 |
Other Current Assets | 138.05 | 65.1 | 50.45 | 185.41 | 420.88 | 411.95 |
Total Current Assets | 1,817 | 2,128 | 1,755 | 2,031 | 1,939 | 1,984 |
Property, Plant & Equipment | 1,578 | 1,535 | 1,597 | 1,655 | 1,937 | 1,724 |
Long-Term Investments | 877.97 | 873.57 | 988.55 | 1,038 | 1,047 | 1,247 |
Goodwill | 2,156 | 2,156 | 2,156 | 2,156 | 2,156 | 2,156 |
Other Intangible Assets | 283.72 | 311.49 | 366.05 | 420.67 | 476.06 | 531.44 |
Long-Term Accounts Receivable | 2.97 | 2.93 | 3.51 | 5.25 | 6.43 | 16.12 |
Long-Term Deferred Tax Assets | 42.24 | 35.86 | 28.03 | 21.19 | 18.18 | 7.63 |
Other Long-Term Assets | 134.1 | 156.21 | 155.86 | 122.76 | 340.97 | 378.73 |
Total Assets | 6,892 | 7,199 | 7,051 | 7,450 | 7,921 | 8,045 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 391.92 | 212.24 | 309.36 | 245.76 | 326.13 | 281.05 |
Accrued Expenses | 78.84 | 101.12 | 98.01 | 133.35 | 140.37 | 105.85 |
Short-Term Debt | 265.71 | 575.33 | 260.71 | 538.03 | 373.94 | 228.9 |
Current Portion of Long-Term Debt | 328.98 | 394.23 | 288.68 | 411.48 | 1,540 | 4.15 |
Current Portion of Leases | 3.87 | 2.79 | 3.09 | 2.93 | 2.27 | 5.69 |
Current Income Taxes Payable | 6.88 | 23.23 | 28.87 | 32.02 | 41.63 | 41.31 |
Current Unearned Revenue | 42.65 | 38.46 | 50.98 | 36.42 | 44.24 | 50.01 |
Other Current Liabilities | 63.54 | 63.76 | 86.95 | 134.19 | 204 | 209.64 |
Total Current Liabilities | 1,182 | 1,411 | 1,127 | 1,534 | 2,673 | 926.6 |
Long-Term Debt | 273.61 | 331.19 | 705.92 | 922.01 | 880.96 | 2,388 |
Long-Term Leases | 25.95 | 27.05 | 25.65 | 28.76 | 25.8 | 27.77 |
Long-Term Unearned Revenue | 29.93 | 29.42 | 33 | 55.02 | 73.12 | 75.27 |
Pension & Post-Retirement Benefits | - | 4.14 | 6.34 | - | - | - |
Long-Term Deferred Tax Liabilities | 63.09 | 68.2 | 73.85 | 69.19 | 92.2 | 117.73 |
Other Long-Term Liabilities | 1,346 | 1,322 | 1,263 | 1,153 | 571.5 | 595.85 |
Total Liabilities | 2,921 | 3,193 | 3,234 | 3,762 | 4,316 | 4,131 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.36 | 0.36 | 0.37 | 0.37 | 0.33 | 0.33 |
Additional Paid-In Capital | 3,799 | 3,842 | 3,874 | 3,874 | 3,637 | 3,637 |
Retained Earnings | 172.62 | 92.55 | -127.21 | -294.51 | -178.4 | 350.08 |
Treasury Stock | -126.63 | -129.04 | -157.67 | -134.65 | -134.65 | -134.65 |
Comprehensive Income & Other | 116.5 | 190.43 | 212.73 | 242.54 | 280.48 | 60.65 |
Total Common Equity | 3,962 | 3,997 | 3,802 | 3,688 | 3,605 | 3,913 |
Minority Interest | 8.9 | 9.78 | 13.84 | - | - | - |
Shareholders' Equity | 3,971 | 4,006 | 3,816 | 3,688 | 3,605 | 3,913 |
Total Liabilities & Equity | 6,892 | 7,199 | 7,051 | 7,450 | 7,921 | 8,045 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 898.12 | 1,331 | 1,284 | 1,903 | 2,823 | 2,655 |
Net Cash (Debt) | 126.93 | -241.82 | -342.34 | -866.9 | -2,144 | -1,854 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.06 | -0.10 | -0.12 | -0.43 | -1.12 | -0.94 |
Filing Date Shares Outstanding | 2,077 | 2,111 | 2,113 | 2,142 | 1,915 | 1,915 |
Total Common Shares Outstanding | 2,077 | 2,111 | 2,113 | 2,142 | 1,915 | 1,915 |
Working Capital | 634.43 | 717.03 | 628.21 | 496.74 | -733.75 | 1,057 |
Book Value Per Share | 1.91 | 1.89 | 1.80 | 1.72 | 1.88 | 2.04 |
Tangible Book Value | 1,522 | 1,529 | 1,280 | 1,111 | 972.23 | 1,225 |
Tangible Book Value Per Share | 0.73 | 0.72 | 0.61 | 0.52 | 0.51 | 0.64 |
Buildings | - | 773.8 | 759.47 | 558.65 | 553.56 | 293.19 |
Machinery | - | 985.65 | 926.64 | 805.36 | 703.13 | 552.49 |
Construction In Progress | - | 93.5 | 109.54 | 338.48 | 469.88 | 542.03 |
Leasehold Improvements | - | 21.85 | 26.29 | 26.29 | 26.29 | 37.07 |
Order Backlog | - | - | - | - | - | 965 |